Eng Eong Ooi
Eng Eong Ooi
Duke-NUS Medical School
Verified email at duke-nus.edu.sg - Homepage
Cited by
Cited by
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
N Le Bert, AT Tan, K Kunasegaran, CYL Tham, M Hafezi, A Chia, ...
Nature 584 (7821), 457-462, 2020
Dengue prevention and 35 years of vector control in Singapore
EE Ooi, KT Goh, DJ Gubler
Emerging infectious diseases 12 (6), 887, 2006
Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study
JA Crump, AB Morrissey, WL Nicholson, RF Massung, RA Stoddard, ...
PLoS neglected tropical diseases 7 (7), e2324, 2013
Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness
G Manokaran, E Finol, C Wang, J Gunaratne, J Bahl, EZ Ong, HC Tan, ...
Science 350 (6257), 217-221, 2015
Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs
ELC Tan, EE Ooi, CY Lin, HC Tan, AE Ling, B Lim, LW Stanton
Emerging infectious diseases 10 (4), 581, 2004
Seroepidemiology of human enterovirus 71, Singapore
EE Ooi, MC Phoon, B Ishak, SH Chan
Emerging infectious diseases 8 (9), 995, 2002
IL-1β, IL-6, and RANTES as biomarkers of Chikungunya severity
LFP Ng, A Chow, YJ Sun, DJC Kwek, PL Lim, F Dimatatac, LC Ng, EE Ooi, ...
PloS one 4 (1), e4261, 2009
A Wilder-Smith, EE Ooi, O Horstick, B Wills
The Lancet 393 (10169), 350-363, 2019
Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries
J Barniol, R Gaczkowski, EV Barbato, RV da Cunha, D Salgado, ...
BMC infectious diseases 11 (1), 1-12, 2011
Naturally acquired human Plasmodium knowlesi infection, Singapore
OT Ng, EE Ooi, CC Lee, PJ Lee, LC Ng, SW Pei, TM Tu, JP Loh, YS Leo
Emerging infectious diseases 14 (5), 814, 2008
Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness
L Tanner, M Schreiber, JGH Low, A Ong, T Tolfvenstam, YL Lai, LC Ng, ...
PLoS neglected tropical diseases 2 (3), e196, 2008
The structural basis for serotype-specific neutralization of dengue virus by a human antibody
EP Teoh, P Kukkaro, EW Teo, APC Lim, TT Tan, A Yip, W Schul, M Aung, ...
Science translational medicine 4 (139), 139ra83-139ra83, 2012
Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial
NI Paton, L Lee, Y Xu, EE Ooi, YB Cheung, S Archuleta, G Wong, ...
The Lancet infectious diseases 11 (9), 677-683, 2011
A dynamic immune response shapes COVID-19 progression
EZ Ong, YFZ Chan, WY Leong, NMY Lee, S Kalimuddin, SMH Mohideen, ...
Cell host & microbe 27 (6), 879-882. e2, 2020
Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development
A Wilder-Smith, EE Ooi, SG Vasudevan, DJ Gubler
Current infectious disease reports 12 (3), 157-164, 2010
Dengue in Southeast Asia: epidemiological characteristics and strategic challenges in disease prevention
EE Ooi, DJ Gubler
Cadernos de saude publica 25, S115-S124, 2009
Early Dengue infection and outcome study (EDEN)-study design and preliminary findings
JGH Low, EE Ooi, T Tolfvenstam, YS Leo, ML Hibberd, LC Ng, YL Lai, ...
A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis
YJ Tan, E Teng, S Shen, THP Tan, PY Goh, BC Fielding, EE Ooi, HC Tan, ...
Journal of virology 78 (13), 6723-6734, 2004
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
JG Low, C Sung, L Wijaya, Y Wei, APS Rathore, S Watanabe, BH Tan, ...
The Lancet infectious diseases 14 (8), 706-715, 2014
Cost-effective real-time reverse transcriptase PCR (RT-PCR) to screen for Dengue virus followed by rapid single-tube multiplex RT-PCR for serotyping of the virus
YL Lai, YK Chung, HC Tan, HF Yap, G Yap, EE Ooi, LC Ng
Journal of clinical microbiology 45 (3), 935-941, 2007
The system can't perform the operation now. Try again later.
Articles 1–20